Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 85.70B | 83.85B | 80.26B | 85.75B | 72.30B | 55.95B |
Gross Profit | 33.08B | 31.87B | 27.71B | 27.15B | 24.69B | 19.22B |
EBITDA | 22.85B | 22.40B | 17.81B | 17.59B | 16.00B | 12.00B |
Net Income | 14.59B | 14.08B | 10.92B | 10.55B | 9.68B | 7.13B |
Balance Sheet | ||||||
Total Assets | 121.98B | 130.59B | 118.17B | 107.27B | 101.19B | 85.11B |
Cash, Cash Equivalents and Short-Term Investments | 43.69B | 52.15B | 38.22B | 32.66B | 31.10B | 30.59B |
Total Debt | 1.27B | 1.23B | 1.32B | 1.14B | 1.12B | 834.37M |
Total Liabilities | 21.64B | 24.47B | 25.46B | 22.90B | 22.48B | 15.63B |
Stockholders Equity | 100.34B | 106.12B | 92.71B | 84.36B | 78.71B | 69.47B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 17.00B | 10.13B | 7.37B | 4.70B | 7.33B |
Operating Cash Flow | 0.00 | 19.20B | 12.44B | 13.46B | 7.42B | 8.68B |
Investing Cash Flow | 0.00 | -3.59B | -1.12B | -6.71B | -4.69B | -3.91B |
Financing Cash Flow | 0.00 | -3.53B | -6.27B | -7.55B | -3.79B | -1.78B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | ¥146.57B | 10.69 | 13.95% | 2.98% | 4.47% | 29.40% | |
81 Outperform | ¥77.24B | 9.73 | 0.85% | 2.19% | 11.03% | ||
80 Outperform | ¥153.14B | 11.61 | 3.84% | 5.75% | -1.75% | ||
78 Outperform | ¥33.40B | 3.56 | 4.16% | 0.79% | 104.86% | ||
76 Outperform | ¥36.98B | 15.70 | 4.72% | 13.35% | 36.31% | ||
72 Outperform | ¥27.42B | 11.87 | 3.12% | 5.18% | 30.87% | ||
62 Neutral | $10.21B | 10.03 | -0.16% | 2.84% | 2.22% | -32.59% |